Symbicort 80-4.5 MCG inhaler 10.2GM
Ended Awarded
- Contract number
- SPE2DB26FJRVX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,581
Award facts
- Contract value 100% obligated
- $1,580.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $1,580.76 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Symbicort 80-4.5 mcg inhaler (10.2 grams). This firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and includes no set-aside designation. DMS Pharmaceutical Group Inc. will perform the work at its location in Park Ridge, Illinois. The award represents a routine pharmaceutical supply transaction under the company's broader contracting relationship with the DLA.
This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide pharmaceutical acquisition strategy. The PPV-G GEN V contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes the DLA to issue firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support Department of Defense medical facilities globally. As a prime vendor contractor under this program, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity, supplying a comprehensive portfolio of medications ranging from specialty treatments to routine pharmaceuticals supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB26FJRVX?
SPE2DB26FJRVX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FJRVX worth?
The government has obligated $1,581 on SPE2DB26FJRVX.
Is contract SPE2DB26FJRVX an order under another contract?
Yes. SPE2DB26FJRVX is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRVX competed?
The extent of competition for SPE2DB26FJRVX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award